Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 327
- 试验地点
- 1
- 主要终点
- Prevalence of positive trypanosoma cruzi serologies
研究概览
简要总结
Chagas disease is endemic to the Americas, infecting between 16-18 million individuals. In immigrant populations in the United States from endemic areas, it is estimated up to 4.9% may be asymptomatic carriers of Trypanosoma cruzi, the organism which causes Chagas disease. Between 10-20% of these patients progress to development of end-stage cardiomyopathy with a high associated morbidity. Following acute disease, patients enter into an indeterminate phase which can last 10-20 years. The earliest sign of cardiac involvement usually is electrocardiogram abnormalities. The most common abnormality is right bundle branch block (RBBB), followed by left anterior fascicular block (LAFB), and left bundle branch block (LBBB). Recent studies have shown that treatment of patients at this stage with antiparasitics may delay the progression of overt cardiomyopathy.
At the University of California, Los Angeles, there is a large population of immigrant patients from countries endemic to Chagas disease. The researchers propose that screening patients with conduction abnormalities on electrocardiogram may be a potentially useful method to identify patients with early cardiac manifestations of Chagas disease. The researchers hope to enroll approximately 300 individuals with RBBB, LAFB or LBBB on electrocardiogram to determine the incidence of Chagas disease in this patient population.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •One of the following EKG abnormalities:
- •Complete or incomplete right bundle branch block (RBBB)
- •Left anterior fascicular block (LAFB)
- •Left bundle branch block (LBBB)
- •Residence at any point in past in an endemic area (any country in Central or South America or Mexico) for at least 12 months.
- •Age >18 and <60.
排除标准
- •Ejection fraction <40%
- •Symptomatic heart failure
- •Documented coronary artery disease
结局指标
主要结局
Prevalence of positive trypanosoma cruzi serologies
时间窗: At enrollment
次要结局
未报告次要终点
研究者
Sheba Meymandi
Principal Investigator
University of California, Los Angeles
